Gevo (NASDAQ:GEVO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have ...

Investors and other persons interested in learning more about the virtual investor presentation can find information and registration details at the following link: About Gevo Gevo is a ...

Highlights,Gevo develops sustainable fuels as an alternative to traditional energy sources.,HC Wainwright set a $14.00 target, while UBS Group raised its estimate to $3.25.,Major investors, including ...

AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

Dow Jones rose on Thursday while the S&P 500 and the Nasdaq built more support at the 50-day moving average in the stock ...

Palantir Technologies (NASDAQ:PLTR – Get Free Report) had its price objective increased by research analysts at DA Davidson from $47.00 to $105.00 in a note issued to investors on Tuesday,Benzinga ...

Highlights,Blue Trust Inc. increased its holdings by 600.5% in Q4.,Financial firms raised price targets, showing confidence ...